Genzyme's (GENZ +0.2%) board unanimously recommends its shareholders accept a $20.1B takeover...

|By:, SA News Editor

Genzyme's (GENZ +0.2%) board unanimously recommends its shareholders accept a $20.1B takeover offer from Sanofi-Aventis (SNY -0.3%). Earlier, Sanofi extended its offer (the second-largest biotech deal ever) to April 1. (PR)